Antonio Palumbo

Antonio Palumbo

Company: GlaxoSmithKline

Job title: MD Global Medical Expert


Sharing the Story of Belantamab Mafodotin (BLENREP) & What Comes Next 9:30 am

BLENREP is indicated for the treatment of adults with relapsed or refractory multiple myeloma who have received at least 4 prior therapies, including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent Review preclinical data that suggests potential for enhanced clinical activity of belantamab mafodotin when administered in combination with other standard-of-care and…Read more

day: day 1 opps
day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.